Diagnostic and Interventional Cardiology

Feature | By Dave Fornell, Editor

February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

February 01, 2021

Medtronic's DiamondTemp Ablation (DTA) system is FDA cleared to treat patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy. The DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds currently available to deliver ablations.

News | Atrial Fibrillation

FDA Clears Medtronic DiamondTemp Ablation System to Treat Atrial Fibrillation

January 29, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic's DiamondTemp Ablation (DTA) system ...

January 29, 2021

News

North American Medical Devices Deals Drops in late 2020

January 29, 2020 — North America’s medical devices industry saw a drop of 17.3% in overall deal activity during the ...

January 29, 2021

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC.

Feature | Atrial Fibrillation | By John D. Day, M.D., T. Jared Bunch, M.D., and Matthew D. LaPlante

Addressing Atrial Fibrillation in the World of COVID-19

In our most challenging and distressing days, it is nice to think about a post-COVID-19 world. But while this pandemic ...

January 27, 2021

The Philips AAA Model integrates software and Philips 3-D ultrasound technologies into a single solution to automatically segment and quantify the size of the aneurysm sac for surveillance of known native and post-EVAR treated AAAs.

News | Cardiovascular Ultrasound

Philips 3-D Ultrasound Offers New Surveillance Method for Abdominal Aortic Aneurysms

January 27, 2021 — Philips Healthcare has introduced the Philips Abdominal Aortic Aneurysm (AAA) Model, providing ...

January 27, 2021

Heavily calcified coronary arteries seen on a CT scan of the heart. Research at the New York Institute of Technology will create blood flow modeling to show the impact of calcium in arteries as part of a project to develop treatments to remove calcium.

News | Cardiovascular Clinical Studies

Vascular Decalcification as Heart Disease Treatment Examined in $1.8 Million NIH Grant

January 27, 2021 — A New York Institute of Technology research team has secured a five-year $1.8 million grant from the ...

January 27, 2021

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.

News | Heart Failure

Occlutech's Atrial Flow Regulator for Heart Failure Receives FDA Breakthrough Device Designation

January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation ...

January 27, 2021

The Pedra Blood Perfusion Index tracks real-time changes in foot tissue perfusion attendant with balloon inflation and deflation during an angioplasty procedure.

News | Peripheral Artery Disease (PAD)

Pedra Tissue Perfusion System Receives FDA Breakthrough Device Designation

January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug ...

January 26, 2021

News | Stents Drug Eluting

FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions

January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug ...

January 26, 2021

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

FDA clears Verquvo, Vericiguat, Heart failure drug.

News | Heart Failure

FDA Clears Vericiguat to Treat Heart Failure Following Hospitalization

January 25, 2021 — The U.S. Food and Drug Administration (FDA) approved Merck's Verquvo (vericiguat). It is the first ...

January 25, 2021

An example of 3-D computer aided design (CAD) software from Materialise being used at Henry Ford Hospital to evaluate left ventricular outflow tract (LVOT) obstruction from a Sapian TAVR valve virtually implanted in the mitral valve position. Henry Ford uses both 3-D printing and CAD to plan and guide complex structural heart procedures.

Feature | Medical 3-D Printing | By Dave Fornell, Editor

3-D Printing and Computer Aided Design Aids Structural Heart Interventions

With increasing complexity of interventional structural heart disease and congenital heart disease interventions, 3-D ...

January 24, 2021

Cardiologists are taking a closer look at the possible long-term cardiovascular effects on COVID long-hauler patients who still show symptoms long after they should be recovered from the virus. Getty Images

Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

The Long-term Cardiovascular Impact of COVID-19

With nearly a year of experience with the COVID-19 (SARS-CoV-2) virus, it has been found that some post-COVID patients ...

January 22, 2021

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

COVID-19 has had a major impact on cardiology and every week new information comes out on the impact of the virus on the heart. #COVID19

Blog | Coronavirus (COVID-19)

The New Normal in 2021 and Hope for the Post-COVID Future

As of January 2021, in the United States we are now on month 10 of the COVID-19 pandemic. One year ago, we followed ...

January 21, 2021

HeartSciences has been developing a new type of ECG system called Wavelet ECG that may offer a new way of looking at the heart. The MyoVista system uses continuous wavelet transform (CWT) signal processing to provide new frequency and energy information to detect cardiac relaxation abnormalities associated with left ventricular diastolic dysfunction commonly associated with hypertension, diabetes, valvular disease, ischemia, and reduced systolic function. Artificial intelligence is used to read the exam.

Feature | ECG | By Dave Fornell, Editor

6 Trends In ECG Systems

Here are a few trends to watch for in electrocardiogram (ECG, or if you prefer the original German EKG) systems. The ...

January 20, 2021

A new CMS national coverage determination for reimbursement for MitraClip significantly expand access to transcatheter mitral valve repair procedures for secondary mitral regurgitation.

News | Heart Valve Technology

Medicare Expands Coverage for MitraClip in Heart Failure Patients

January 20, 2021 — The U.S. Centers for Medicare and Medicaid Services (CMS) revised its National Coverage Determination ...

January 20, 2021